Company / PP&E (Net)
Bio-Rad Laboratories PP&E (Net) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$539.9M
FY2025
5-year range
$498.6M / $539.9M
FY2021-FY2025
Trend
+2.2%
vs FY2024
Sector context
#47 of 130
Health Care
What the data says
At $540M, Bio-Rad Laboratories's pp&e (net) ranks #47 of 130 in the Health Care sector. PP&E (Net) has fluctuated over the past 10 years, ranging from $489M in FY2016 to $540M in FY2025.
Based on SEC 10-K filings.
$540M in FY2025 with a 5-year CAGR of +1.9%.
Improved from $529M to $540M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +2.7%
- 5-Year CAGR
- +1.9%
- 10-Year CAGR
- -
Sector benchmark
#47 of 130 in Health CareTop 36% of 130This company $539.9M Sector average $1.3B
▼
-59.8% below sector average
Key checks
Key Insights
- 5-year CAGR of +1.9%, indicating consistent growth.
- In FY2025, pp&e (net) increased 2.2% year-over-year.
- Ranks #47 out of 130 companies in the Health Care sector.
- Lowest pp&e (net) in the period was in FY2016.
Company context
Key Data Points
- Strong return on equity: 23.0%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $539.9M | +2.2% |
| FY2024 | $528.1M | -0.2% |
| FY2023 | $529.0M | +6.1% |
| FY2022 | $498.6M | -2.5% |
| FY2021 | $511.6M | +4.1% |
| FY2020 | $491.4M | -1.6% |
| FY2019 | $499.3M | -1.8% |
| FY2018 | $508.7M | +3.1% |
| FY2017 | $493.5M | +1.0% |
| FY2016 | $488.6M | +11.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026